Treatment of depression with atypical features:: A meta-analytic approach

被引:78
作者
Henkel, V
Mergl, R
Allgaier, AK
Kohnen, R
Möller, HJ
Hegerl, U
机构
[1] Univ Munich, Clin Neurophysiol Lab, Dept Psychiat, D-80336 Munich, Germany
[2] Inst Med Res Managemetn & Biometr, IMEREM, D-90478 Nurnberg, Germany
关键词
meta-analysis; drug trial; monoamine oxidase inhibitors; selective serotonin reuptake inhibitors; tricyclic antidepressants;
D O I
10.1016/j.psychres.2005.07.012
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The present meta-analysis addressed the empirical evidence regarding the treatment of major depression with atypical features. The superiority of monoamine oxidase inhibitors (MAOIs) compared with other antidepressants in the treatment of major depression with atypical features has been frequently reported. According to the CONSORT Statement, studies included in our meta-analysis had to meet several criteria, especially a double-blind, controlled condition and an operational diagnosis according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-III or DSM-IV criteria, respectively. Four databases for research-based evidence were used in a systematic review: Medline, Embase, Psyndex and PsycInfo. Only eight publications met inclusion/exclusion criteria, resulting in 11 comparisons. Our results contrast an effect size of 0.45 (95% confidence interval) for a comparison of MAOIs vs. placebo with an effect size of 0.02 (95% confidence interval: -0.10-0.14) for a comparison of MAOIs vs. selective serotonin reuptake inhibitors. The effect size for MAOIs vs. tricyclic antidepressants was 0.27 (95% confidence interval: 0.16-0.42). MAOIs may be more effective for atypical major depressive disorder than tricyclic antidepressants. Most clinical research has been conducted on irreversible MAOIs. Additional studies testing more recently developed antidepressants (including reversible MAOIs) with an improved safety profile would be warranted. The available data are insufficient for a direct comparison between MAOIs and selective serotonin reuptake inhibitors. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:89 / 101
页数:13
相关论文
共 101 条
[1]   Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression [J].
Agosti, V ;
McGrath, PJ .
JOURNAL OF AFFECTIVE DISORDERS, 2002, 71 (1-3) :113-120
[2]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[3]  
ALTMAN DG, 1998, BRIT MED J, V317, P989
[4]  
*AM PSYCH ASS, 2000, PRACT GUID MAJ DEPR
[5]  
American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, P5
[6]   Toward validation of atypical depression in the community: results of the Zurich cohort study [J].
Angst, J ;
Gamma, A ;
Sellaro, R ;
Zhang, HP ;
Merikangas, K .
JOURNAL OF AFFECTIVE DISORDERS, 2002, 72 (02) :125-138
[7]  
[Anonymous], 1978, Schedule for Affective Disorders and Schizophrenia-Change version
[8]  
[Anonymous], RIV SPERIMENTALE FRE
[9]  
ASNIS GM, 1995, AM J PSYCHIAT, V152, P31
[10]   The effects of seasons and light therapy on G protein levels in mononuclear leukocytes of patients with seasonal affective disorder [J].
Avissar, S ;
Schreiber, G ;
Nechamkin, Y ;
Neuhaus, I ;
Lam, GK ;
Schwartz, P ;
Turner, E ;
Matthews, J ;
Naim, S ;
Rosenthal, NE .
ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (02) :178-183